A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.
Opinion | ‘The Most Bang for Its Buck’: What We Heard This Week
“This strategy has ‘the most bang for its buck’.” — Sara Karaba, MD, PhD, MHS, of Johns Hopkins University School of Medicine in Baltimore, on
July 8, 2024